As of 2025-09-16, the Relative Valuation of Syros Pharmaceuticals Inc (SYRS) is (2,155.03) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.12 USD, the upside of Syros Pharmaceuticals Inc based on Relative Valuation is -1838863.0%.
The range of the Relative Valuation is (1,703.92) - (2,839.86) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.4x - 11.3x | 7.8x |
| Forward P/E multiples | 6.8x - 11.8x | 9.3x |
| Fair Price | (1,703.92) - (2,839.86) | (2,155.03) |
| Upside | -1453955.8% - -2423192.9% | -1838863.0% |
| Date | P/E |
| 2025-09-10 | -0.00 |
| 2025-09-09 | -0.00 |
| 2025-09-08 | -0.00 |
| 2025-09-05 | -0.00 |
| 2025-09-04 | -0.00 |
| 2025-09-03 | -0.00 |
| 2025-09-02 | -0.00 |
| 2025-08-29 | -0.00 |
| 2025-08-28 | -0.00 |
| 2025-08-27 | -0.00 |
| 2025-08-26 | -0.00 |
| 2025-08-25 | -0.00 |
| 2025-08-22 | -0.00 |
| 2025-08-21 | -0.00 |
| 2025-08-20 | -0.00 |
| 2025-08-19 | -0.00 |
| 2025-08-18 | -0.00 |
| 2025-08-15 | -0.00 |
| 2025-08-14 | -0.00 |
| 2025-08-13 | -0.00 |
| 2025-08-12 | -0.00 |
| 2025-08-11 | -0.00 |
| 2025-08-08 | -0.00 |
| 2025-08-07 | -0.00 |
| 2025-08-06 | -0.00 |
| 2025-08-05 | -0.00 |
| 2025-08-04 | -0.00 |
| 2025-08-01 | -0.00 |
| 2025-07-31 | -0.00 |
| 2025-07-30 | -0.00 |
| 2025-07-29 | -0.00 |
| 2025-07-28 | -0.00 |
| 2025-07-25 | -0.00 |
| 2025-07-24 | -0.00 |
| 2025-07-23 | -0.00 |
| 2025-07-22 | -0.00 |
| 2025-07-21 | -0.00 |
| 2025-07-18 | -0.00 |
| 2025-07-17 | -0.00 |
| 2025-07-16 | -0.00 |
| 2025-07-15 | -0.00 |
| 2025-07-14 | -0.00 |
| 2025-07-11 | -0.00 |
| 2025-07-10 | -0.00 |
| 2025-07-09 | -0.00 |
| 2025-07-08 | -0.00 |
| 2025-07-07 | -0.00 |
| 2025-07-03 | -0.00 |
| 2025-07-02 | -0.00 |
| 2025-07-01 | -0.00 |